Yang Hong-Jia, Zhang Zheng, Wang Zuo-Min
Department of Stomatology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin 300041, China.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Jan;54(1):54-60. doi: 10.12182/20230160502.
Oral microbiota have a complex impact on the host's health and disease states. It has been found that the composition of lung flora bears a striking resemblance to the composition of oral flora. Moreover, oral pathogenic bacteria have been detected in the sputum and bronchoalveolar lavage fluid of patients with chronic obstructive pulmonary disease (COPD), suggesting that oral microbiota play an important role in the pathogenesis and development of COPD. Findings from lots of studies have shown that oral microbiota may participate in the pathogenesis and development of COPD through non-specific immune response, specific immune response, and the activities of protein hydrolase. Herein, we mainly summarized the available evidence on the relationship between oral microbiota and COPD. By examining the relationship between the two, we elaborated on the application of oral microbiota in the diagnosis and prevention of COPD, discussed possible directions for future research, and provided references for developing new therapeutic approaches.
口腔微生物群对宿主的健康和疾病状态有着复杂的影响。研究发现,肺部菌群的组成与口腔菌群的组成极为相似。此外,在慢性阻塞性肺疾病(COPD)患者的痰液和支气管肺泡灌洗液中已检测到口腔致病细菌,这表明口腔微生物群在COPD的发病机制和发展过程中起着重要作用。大量研究结果表明,口腔微生物群可能通过非特异性免疫反应、特异性免疫反应以及蛋白水解酶的活性参与COPD的发病机制和发展过程。在此,我们主要总结了关于口腔微生物群与COPD之间关系的现有证据。通过研究两者之间的关系,我们阐述了口腔微生物群在COPD诊断和预防中的应用,讨论了未来可能的研究方向,并为开发新的治疗方法提供参考。